Key result
Integrating arterial stiffness and ventricular-vascular interactions into HF phenotyping enhances risk stratification over LVEF alone.
Why the study?
Current HF phenotyping frameworks predominantly emphasize myocardial dysfunction while vascular abnormalities remain underrepresented, despite ventricular-vascular interactions playing a key role in cardiovascular performance.
Does integrating ventricular-vascular interaction and arterial stiffness into patient phenotyping improve risk stratification and personalized therapeutic strategies in heart failure?
Does integrating ventricular-vascular interaction and arterial stiffness into patient phenotyping improve risk stratification and personalized therapeutic strategies in heart failure?
Integrating arterial stiffness and ventricular-vascular interaction into heart failure phenotyping may enhance risk stratification and personalized therapy, particularly in HFpEF.
Answers are grounded in this paper and cite their sources.
Combine: Routine clinical use of multi-modality phenotyping in heart failure remains.
A key limitation in contemporary HF management is the marked heterogeneity of the syndrome, driven by diverse pathophysiological mechanisms that are not fully captured by traditional classifications based on left ventricular ejection fraction. Precision medicine has emerged as a promising approach to address this heterogeneity by integrating clinical characteristics, circulating biomarkers, advanced imaging, and computational phenotyping strategies. However, current frameworks predominantly emphasize myocardial dysfunction, while the contribution of vascular abnormalities remains underrepresented. The interaction between the left ventricle and the arterial system plays a fundamental role in cardiovascular performance. Arterial stiffness, commonly assessed by pulse wave velocity (PWV), represents a key determinant of vascular aging and a robust predictor of cardiovascular risk. Increasing evidence suggests that vascular dysfunction contributes significantly to the pathophysiology and clinical expression of HF, particularly in phenotypes characterized by preserved ejection fraction. This review synthesizes current evidence on precision medicine in HF and highlights the emerging role of arterial stiffness and PWV in multidimensional patient phenotyping. We propose that integrating vascular parameters into existing phenotyping frameworks may enhance risk stratification, improve mechanistic understanding, and support the development of more personalized therapeutic strategies in heart failure. Unlike previous reviews that have addressed arterial stiffness or heart failure phenotyping separately, this work uniquely integrates ventricular–vascular interaction and pulse wave velocity into a comprehensive precision medicine framework for heart failure. By bridging vascular physiology with data-driven phenotyping strategies, this review provides a novel conceptual model for incorporating arterial stiffness into multidimensional patient characterization across the full spectrum of heart failure phenotypes.
No takes yet. Share an insight, caveat, or question.
Petrescu et al. (2026) studied this question. Integrating arterial stiffness and ventricular-vascular interactions into heart failure phenotyping enhances risk stratification and supports personalized therapeutic strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: